Anika Therapeutics Inc (ANIK) financials
Anika Therapeutics revenue and earnings by year
Anika Therapeutics's revenue was $113 million in the fiscal year to December 31, 2025, down 5.9% from the year before. Net income was -$10.9 million, -9.6% of revenue. Since the fiscal year to December 31, 2016, revenue has grown 1.0% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 10 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 113 | 120 | 121 | 114 | 148 | 130 | 115 | 106 | 113 | 103 |
| Revenue growth | -5.9% | -0.7% | 6.1% | -23.0% | 13.3% | 13.8% | 8.6% | -6.9% | 9.7% | — |
| Gross profit | 64 | 76 | 83 | 73 | 83 | 69 | 86 | 74 | 86 | 79 |
| Gross margin | 56.6% | 63.4% | 68.3% | 64.3% | 56.1% | 52.9% | 74.9% | 70.4% | 75.9% | 76.8% |
| Operating income | -11 | -5 | 1 | 4 | -18 | -57 | 34 | 22 | 46 | 51 |
| Operating margin | -9.8% | -4.3% | 0.7% | 3.2% | -12.5% | -43.7% | 29.9% | 20.6% | 40.3% | 49.0% |
| Net income | -11 | -56 | -83 | -15 | 4 | -24 | 27 | 19 | 32 | 33 |
| Net margin | -9.6% | -47.0% | -68.4% | -13.1% | 2.8% | -18.4% | 23.7% | 17.7% | 28.1% | 31.5% |
| Diluted EPS | -$0.76 | -$3.83 | -$5.64 | -$1.02 | $0.28 | -$1.69 | $1.92 | $1.29 | $2.12 | $2.15 |
| Free cash flow | 4 | -3 | -7 | -3 | 3 | 11 | 34 | 30 | 32 | 10 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open ANIK in Markets.
How Anika Therapeutics makes money
Revenue by segment in the quarter to June 30, 2026, as the company reports it.
| Segment | Revenue | Share |
|---|---|---|
| OEM Channel | $18.7M | 57.4% |
| Commercial Channel | $13.9M | 42.6% |
See also: ANIK valuation and P/E history · ANIK returns
No forecast, no recommendation. This page describes Anika Therapeutics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.